web analytics
Breaking News         Burbank KC     09/26/2015     Best In Show Judge: Mr. Edd E. Bivin     Best In Show: CH Vjk-Myst Garbonit'a California Journey     Warrenton KC (2)     09/26/2015     Best In Show Judge: Dr Ronald Spritzer     Best In Show: GCH Hill Country's Tag I'M It     Bonanza KC of Carson City     09/26/2015     Best In Show Judge: Dr. Karen M Ericson     Best In Show: GCH Skyline's Unit Of Measure     Grand Valley KC (3)     09/26/2015     Best In Show Judge: Mrs. Gloria L. Geringer     Best In Show: GCH Sabe's Simply Invincible     Greater Murfreesboro KC     09/26/2015     Best In Show Judge: Pat Trotter     Best In Show: CH Ashdown's Time To Thrill     Best In Show Daily Digital Magazine Info! Petco Celebrates Halloween with a New Lineup of Costumes and Events Points Drake University to Unveil Live Bulldog Mascot Thursday Amanda & Vito Ciaravino – Interview

We'll email you the stories that fanciers want to read from all around the web daily

We don't share your email address

Gene Therapy Shows Promise for Managing Canine Diabetes

The signs of type 1 diabetes in five Beagles were controlled after they were injected with two types of genes by researchers at Spain’s Universitat Autònoma de Barcelona.

The therapy is minimally invasive, according to lead researcher Fàtima Bosch, Ph.D., a professor at the university. A single session of injections goes into the dog’s rear legs, administered with the same needles used for cosmetic treatments like Botox, according to a university press release. “These injections introduce gene therapy vectors, with a dual objective: to express the insulin gene, on the one hand, and that of glucokinase, on the other. When both genes act simultaneously, they function as a ‘glucose sensor,’” reducing diabetic hyperglycemia – the excess of blood sugar associated with diabetes.

The hormone insulin, which helps the body use or store glucose and is normally created in the pancreas, is not created in people or dogs with type 1 diabetes. The enzyme glucokinase regulates how much glucose is taken from the blood by the body.

Diabetic Beagles injected with two genes – Insulin and Glucokinase – showed no further signs of the disease, even after four years. Photo © Can Stock Photo.

“We previously demonstrated that it is possible to generate a ‘glucose sensor’ in skeletal muscle through co-expression of glucokinase (Gck) and insulin (Ins), increasing glucose uptake and correcting hyperglycemia in diabetic mice,” reads the abstract of the paper describing the study. “Here, we demonstrate long-term efficacy of this approach in a large animal model of diabetes.”

The release states that the study is the “first to report optimal long-term control of diabetes in large animals. This had never before been achieved with any other innovative therapies for diabetes. The study is also the first to report that a single administration of genes to diabetic dogs is able to maintain normoglycemia over the long term.”

Injection of the two genes “resulted in normalization of fasting glycemia, accelerated disposal of glucose after oral challenge, and no episodes of hypoglycemia during exercise for [more than] four years after gene transfer,” the study states. “This was associated with recovery of body weight, reduced glycosylated plasma proteins levels and long-term survival without secondary complications.”

The abstract goes on to state that the insulin or glucokinase gene alone “failed to achieve complete correction of diabetes, indicating that the synergistic action of Ins and Gck are needed for full therapeutic effect.”

The treated dogs showed good glucose control, “both when fasting and when fed, improving on that of dogs given daily insulin injections, and with no episodes of hypoglycemia, even after exercise,” the release states.

“Moving from mice to large animals is a big step,” Bosch, director of the Center of Animal Biotechnology and Gene Therapy at the university, told the American Diabetes Association, which publishes the journal, Diabetes.  “If something works well in large animals, we have reason to believe, based on the previous experience in the field of gene transfer, that it is likely that we will see similar outcomes in humans. For example, gene therapy that worked well in large animals to treat hemophilia is now seeing positive results in clinical trials with humans. We hope that in a few years, we’ll be able to test this therapy for type 1 diabetes in humans as well.”

Many patients – both canine and human – with type 1 diabetes, or diabetes mellitus, require insulin to survive. Despite the use of insulin, patients often develop serious secondary complications like blindness or kidney damage and may require amputation of limbs, according to Bosch. “Moreover, in order to achieve good blood glucose control, insulin has to be injected two or three times a day, which brings a risk of hypoglycemia episodes,” the lowering of blood sugar.

“The excellent results obtained for the first time with large animals lay the foundations for the clinical translation of this gene therapy approach to veterinary medicine and eventually to diabetic patients,” the university concludes.

Bosch also told the American Diabetes Association that her team will next test the procedure on “different breeds of dogs that have type 1 diabetes and live with families,” rather than in a lab. It will allow them to “better adjust the insulin doses in different size and breeds of dogs living in ‘real life’ situations. Once they are able to determine how to adjust the therapy in this context, the investigators will be ready to test the treatment on humans.”

The study involved the UAB Department of Biochemistry and Molecular Biology, the UAB Department of Medicine and Animal Surgery, the UAB Faculty of Veterinary Science, the UAB Department of Animal Health and Anatomy, the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, the Children’s Hospital of Philadelphia and the Howard Hughes Medical Institute of Philadelphia. Its results were published in the February 2013 issue of Diabetes and discussed in a May 2013 article in the same journal.

Bosch and some of her colleagues designed a video that explains how gene therapy treats and cures disease.

Written by

Susan Chaney has been on the editorial side of publishing since 1990, starting her career as a newspaper features writer and editor. A lifelong lover of dogs, Susan has lived with German Shepherds, Labs, Yorkies, an Irish Setter, a Great Dane-Bloodhound mix, a Sheltie and currently a Chihuahua mix of unknown pedigree. She was the editor of Dog Fancy magazine, content editor of DogChannel.com and group editor of Dog World, Dogs USA, Puppies USA, Natural Dog, Cat Fancy, Cats USA and Kittens USA from March 2005 to December 2009 when she left her position to work at home, part-time. Susan lives in Long Beach, Calif., with her artist husband, Tim, that Chi mix and two big cats. As an editor and writer for Best In Show Daily, she is reveling in the amalgam of three loves: writing, editing and dogs.
  • teresa June 26, 2013 at 1:40 PM

    Hi I would like the information on the researchers in the US being involved with a breed that is very high on the DM list ,this sounds almost too good to be true but I would like to offer our breed as part of the study.Thank you for your assistance

  • Susan Chaney
    Susan Chaney June 27, 2013 at 9:52 AM

    Thanks for writing, Teresa. Wonderful of you to think of offering your breed. Right now, the research is being done in Spain, but perhaps it will expand to the U.S. in time. You can contact Dr. Bosch at fatima.bosch@uab.es

  • Marianne July 24, 2013 at 6:13 AM

    Would this possibly be able to translate to type 2 diabetes as well in dogs? I have a Westie with type 2.

    • Susan Chaney
      Susan Chaney August 1, 2013 at 10:42 AM

      That remains to be seen, Marianne. I suspect that they will test that possibility in the future.

  • Post a comment